SUBSCRIBE
SUBSCRIBE

Postmarket research

Bookmark and Share
Drug Development
Low-Cost Drugs Prevent Heart Attack, Stroke, Kaiser Permanente Study
October 2, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Dementia Treatment Linked to Heart Troubles, St. Michael’s Hospital in Toronto
September 30, 2009
 · 
1 min read
Drug Development
Heparin Can Cause Skin Lesions, The Johann Wolfgang Goethe University Study
September 29, 2009
 · 
1 min read
Drug Development
Young Women With Autoimmune Condition Need To Be Warned About The Dangers Of Smoking And Use Of Oral Contraceptives, University Medical Center Utrecht Study
September 28, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Men’s Sex Lives May Suffer On Hepatitis C Therapy, Columbia-Presbyterian Medical Center Study
September 17, 2009
 · 
1 min read
Drug Development
Diabetes Drug Kills Cancer Stem Cells In Combination Treatment In Mice, Harvard Medical School Study
September 16, 2009
 · 
1 min read
Bookmark and Share
Drug Development
More Uncertainty For MS Patients Taking Biogen Idec, Inc. (California) And Elan Corporation PLC’s Tysabri; JC Virus Activation Called Common with Tysabri, Beth Israel Deaconess Medical Center Study
September 10, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Cancer Safety Fears Of Most Common Heartburn Treatment Proton Pump Inhibitors (PPI) Rejected By Major Clinical Study At Queen Mary School of Medicine And University of London
September 10, 2009
 · 
1 min read
Bookmark and Share
Drug Development
More Drug Firms Doing Follow-Ups Than Thought, FDA Says; But Audit Does Find Shortcomings in FDA’s system
September 4, 2009
 · 
1 min read
Bookmark and Share
Drug Development
Men Experience Sexual Dysfunction During Hepatitis C Therapy, Study in Gastroenterology Says
September 1, 2009
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Amgen Announces Positive Top-Line Results From Phase 3 Study Of Prolia (Denosumab) In Patients Receiving Glucocorticoid Therapy
August 29, 2016
 · 
16 min read
Drug Development
Merck & Co.'s Keytruda May Have an Edge Over Bristol-Myers Squibb’s Opdivo for Cancer Doctors
August 26, 2016
 · 
1 min read
Drug Development
Armetheon Announces Positive Results Of Pharmacokinetics Study Of Tecarfarin Versus Warfarin
August 25, 2016
 · 
4 min read
Drug Development
Sunovion Pharmaceuticals Inc. Announces Publication Of Data Evaluating Dose Escalation Of Latuda (Lurasidone HCL) In The Treatment Of Schizophrenia
August 8, 2016
 · 
11 min read
Drug Development
Novo Nordisk A/S’s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure
August 4, 2016
 · 
1 min read
Drug Development
Imprimis Release: Peer-Reviewed Study Of Dropless Cataract Surgery Shows ‘Measurable Benefits’ Compared To Drops
July 22, 2016
 · 
6 min read
Drug Development
Amgen And Allergan Biosimilar Found as Effective as Genentech’s Herceptin
July 21, 2016
 · 
14 min read
Drug Development
Pfizer Receives WHO Prequalification For Multi-Dose Vial Presentation Of Prevenar 13
July 19, 2016
 · 
9 min read
Drug Development
Mallinckrodt Warned Over Missing Study About Child Opioids Use
July 8, 2016
 · 
1 min read
Drug Development
FDA Panel Narrowly Backs Cardiovascular Claims for Boehringer Ingelheim, Eli Lilly’s Jardiance
June 29, 2016
 · 
11 min read
Drug Development
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Of INPULSIS Trials Demonstrates Efficacy Of OFEV (Nintedanib) Across A Range Of IPF Patients Using Broader Diagnostic Criteria
June 27, 2016
 · 
9 min read
Drug Development
Roche CEO ‘Sleeping Much Better’ Following Positive News About Three New Drugs
June 23, 2016
 · 
1 min read
Drug Development
FDA Bestows Incyte’s Ruxolitinib with Breakthrough Tag for Graft-Versus-Host Disease
June 23, 2016
 · 
6 min read
Drug Development
Kowa Pharmaceuticals America Release: New Data Demonstrate Pitavastatin More Effective Than Pravastatin In Improving Inflammatory And Immune Activation Markers In HIV-Infected Patients
June 21, 2016
 · 
3 min read
Drug Development
Merck & Co. Release: Systematic Review Of 58 Publications Of Real-World Use Of GARDASIL Presented At EUROGIN Congress
June 16, 2016
 · 
14 min read
Drug Development
Pernix Announces Positive Phase IV Results Of Silenor Vs. Zolpidem Head-To-Head Arousability Study
June 16, 2016
 · 
4 min read
Drug Development
Boehringer Ingelheim And Eli Lilly Release: Jardiance (Empagliflozin) Significantly Reduced The Risk Of Progressive Kidney Disease In Adults With Type 2 Diabetes With Established Cardiovascular Disease
June 14, 2016
 · 
6 min read
Drug Development
AstraZeneca PLC Presents New Data From Multiple Studies On The Effect Of BYDUREON On Glucose Fluctuations In Patients With Type 2 Diabetes
June 13, 2016
 · 
12 min read
Drug Development
Boehringer Ingelheim And Eli Lilly Release: New Study Results Show Trajenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment
June 13, 2016
 · 
3 min read
Drug Development
New Data Presented At The Annual European Congress Of Rheumatology (EULAR 2016) Demonstrate Safety And Efficacy Of Biogen’s Anti-TNF Biosimilars Portfolio
June 9, 2016
 · 
7 min read
Load More